Synergistic effects of PRIMA-1Met (APR-246) and 5-azacitidine in TP53-mutated myelodysplastic syndromes and acute myeloid leukemia

Myelodysplastic syndromes and acute myeloid leukemia with TP53 mutations are characterized by frequent relapses, poor or short responses, and poor survival with the currently available therapies including chemotherapy and 5-azacitidine (AZA). PRIMA-1Met(APR-246,APR) is a methylated derivative of PRI...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Nabih Maslah, Norman Salomao, Louis Drevon, Emmanuelle Verger, Nicolas Partouche, Pierre Ly, Philippe Aubin, Nadia Naoui, Marie-Helene Schlageter, Cecile Bally, Elsa Miekoutima, Ramy Rahmé, Jacqueline Lehmann-Che, Lionel Ades, Pierre Fenaux, Bruno Cassinat, Stephane Giraudier
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Ferrata Storti Foundation 2020-06-01
coleção:	Haematologica
Acesso em linha:	https://haematologica.org/article/view/9429
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!